Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Moderna Inc (Symbol: MRNA), where a total of 76,027 contracts have traded so far, representing approximately 7.6 million underlying shares. That amounts to about 76.9% of MRNA’s average daily trading volume over the past month of 9.9 million shares. Especially high volume was seen for the $170 strike call option expiring January 28, 2022, with 3,377 contracts trading so far today, representing approximately 337,700 underlying shares of MRNA. Below is a chart showing MRNA’s trailing twelve month trading history, with the $170 strike highlighted in orange:

MFA Financial, Inc. (Symbol: MFA) options are showing a volume of 24,102 contracts thus far today. That number of contracts represents approximately 2.4 million underlying shares, working out to a sizeable 72.1% of MFA’s average daily trading volume over the past month, of 3.3 million shares.
Especially high volume was seen for the $5 strike call option expiring January 20, 2023, with 12,156 contracts trading so far today, representing approximately 1.2 million underlying shares of MFA. Below is a chart showing MFA’s trailing twelve month trading history, with the $5 strike highlighted in orange:

And Intel Corp (Symbol: INTC) options are showing a volume of 247,981 contracts thus far today. That number of contracts represents approximately 24.8 million underlying shares, working out to a sizeable 70.8% of INTC’s average daily trading volume over the past month, of 35.0 million shares.
Especially high volume was seen for the $52.50 strike call option expiring May 20, 2022, with 8,538 contracts trading so far today, representing approximately 853,800 underlying shares of INTC. Below is a chart showing INTC’s trailing twelve month trading history, with the $52.50 strike highlighted in orange:

For the various different available expirations for MRNA options, MFA options, or INTC options, visit StockOptionsChannel.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.